Fresenius Medical Care Ag (FMS)

$20.76

-0.72

(-3.35%)

Market is closed - opens 7 PM, 25 Apr 2024

Insights on Fresenius Medical Care Ag

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 4.70B → 4.98B (in $), with an average increase of 1.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 84.35M → 187.92M (in $), with an average increase of 55.1% per quarter

  • Vs DVA

    In the last 1 year, Davita Healthcare Partners Inc. has given 53.4% return, outperforming this stock by 60.7%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 17.9% return, outperforming this stock by 63.4%

Performance

  • $20.69
    $21.00
    $20.76
    downward going graph

    0.34%

    Downside

    Day's Volatility :1.45%

    Upside

    1.12%

    downward going graph
  • $16.37
    $27.72
    $20.76
    downward going graph

    21.15%

    Downside

    52 Weeks Volatility :40.95%

    Upside

    25.11%

    downward going graph

Returns

PeriodFresenius Medical Care AgSector (Health Care)Index (Russel 2000)
3 Months
7.72%
2.0%
0.0%
6 Months
23.8%
11.7%
0.0%
1 Year
-7.73%
5.8%
1.3%
3 Years
-45.32%
14.2%
-22.1%

Highlights

Market Capitalization
12.2B
Book Value
$46.42
Dividend Share
1.19
Dividend Yield
3.09%
Earnings Per Share (EPS)
0.91
PE Ratio
22.58
PEG Ratio
0.39
Wall Street Target Price
18.6
Profit Margin
2.57%
Operating Margin TTM
9.93%
Return On Assets TTM
2.73%
Return On Equity TTM
4.84%
Revenue TTM
19.5B
Revenue Per Share TTM
33.15
Quarterly Revenue Growth YOY
-0.2%
Gross Profit TTM
5.3B
EBITDA
2.4B
Diluted Eps TTM
0.91
Quarterly Earnings Growth YOY
0.35
EPS Estimate Current Year
2.02
EPS Estimate Next Year
2.54
EPS Estimate Current Quarter
0.32
EPS Estimate Next Quarter
0.37

Analyst Recommendation

Hold
    30%Buy
    53%Hold
    15%Sell
Based on 26 Wall street analysts offering stock ratings for Fresenius Medical Care Ag(by analysts ranked 0 to 5 stars)
Based on 26 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
4
3
Hold
14
16
15
Sell
4
8
9

Analyst Forecast

What analysts predicted

Downside of 10.4%

Current $20.76
Target $18.60

Company Financials

FY18Y/Y Change
Revenue
18.9B
↓ 6.96%
Net Income
2.3B
↑ 54.84%
Net Profit Margin
11.98%
↑ 4.78%
FY19Y/Y Change
Revenue
19.6B
↑ 5.62%
Net Income
1.3B
↓ 39.46%
Net Profit Margin
6.87%
↓ 5.11%
FY20Y/Y Change
Revenue
22.0B
↑ 2.19%
Net Income
1.4B
↓ 2.97%
Net Profit Margin
6.52%
↓ 0.35%
FY21Y/Y Change
Revenue
20.0B
↓ 1.34%
Net Income
1.1B
↓ 16.75%
Net Profit Margin
5.5%
↓ 1.02%
FY22Y/Y Change
Revenue
20.8B
↑ 10.1%
Net Income
721.4M
↓ 30.53%
Net Profit Margin
3.47%
↓ 2.03%
FY23Y/Y Change
Revenue
19.5B
↑ 0.29%
Net Income
499.0M
↓ 25.9%
Net Profit Margin
2.57%
↓ 0.9%
Q3 FY22Q/Q Change
Revenue
5.0B
↑ 7.14%
Net Income
226.2M
↑ 11.7%
Net Profit Margin
4.52%
↑ 0.19%
Q4 FY22Q/Q Change
Revenue
5.4B
↓ 1.95%
Net Income
207.8M
↓ 15.69%
Net Profit Margin
3.88%
↓ 0.64%
Q1 FY23Q/Q Change
Revenue
5.1B
↓ 5.86%
Net Income
146.0M
↓ 31.0%
Net Profit Margin
2.85%
↓ 1.03%
Q2 FY23Q/Q Change
Revenue
5.3B
↑ 2.57%
Net Income
153.1M
↑ 4.86%
Net Profit Margin
2.91%
↑ 0.06%
Q3 FY23Q/Q Change
Revenue
4.9B
↑ 2.3%
Net Income
84.4M
↓ 39.9%
Net Profit Margin
1.71%
↓ 1.2%
Q4 FY23Q/Q Change
Revenue
5.0B
↑ 1.05%
Net Income
187.9M
↑ 122.79%
Net Profit Margin
3.77%
↑ 2.06%
FY18Y/Y Change
Total Assets
30.0B
↑ 9.23%
Total Liabilities
15.3B
↑ 1.08%
FY19Y/Y Change
Total Assets
36.9B
↑ 25.5%
Total Liabilities
22.1B
↑ 47.74%
FY20Y/Y Change
Total Assets
39.0B
↓ 3.78%
Total Liabilities
23.8B
↓ 1.78%
FY21Y/Y Change
Total Assets
38.9B
↑ 8.45%
Total Liabilities
23.1B
↑ 5.32%
FY22Y/Y Change
Total Assets
38.3B
↑ 4.04%
Total Liabilities
21.8B
↓ 0.41%
FY23Y/Y Change
Total Assets
33.9B
↓ 5.1%
Total Liabilities
19.1B
↓ 5.92%
Q3 FY22Q/Q Change
Total Assets
37.8B
↑ 6.48%
Total Liabilities
21.3B
↑ 5.1%
Q4 FY22Q/Q Change
Total Assets
38.3B
↓ 6.91%
Total Liabilities
21.8B
↓ 6.3%
Q1 FY23Q/Q Change
Total Assets
38.7B
↓ 0.71%
Total Liabilities
22.1B
↓ 0.15%
Q2 FY23Q/Q Change
Total Assets
38.1B
↓ 1.52%
Total Liabilities
21.9B
↓ 1.2%
Q3 FY23Q/Q Change
Total Assets
35.6B
↑ 1.93%
Total Liabilities
20.2B
↑ 0.85%
Q4 FY23Q/Q Change
Total Assets
33.9B
↓ 4.78%
Total Liabilities
19.1B
↓ 5.43%
FY18Y/Y Change
Operating Cash Flow
2.4B
↓ 5.93%
Investing Cash Flow
-280.3M
↓ 75.29%
Financing Cash Flow
-779.9M
↓ 14.64%
FY19Y/Y Change
Operating Cash Flow
2.9B
↑ 24.49%
Investing Cash Flow
-3.7B
↑ 1241.01%
Financing Cash Flow
-522.7M
↓ 31.55%
FY20Y/Y Change
Operating Cash Flow
5.2B
↑ 64.9%
Investing Cash Flow
-1.6B
↓ 59.37%
Financing Cash Flow
-3.3B
↑ 470.9%
FY21Y/Y Change
Operating Cash Flow
2.8B
↓ 41.2%
Investing Cash Flow
-1.4B
↓ 10.39%
Financing Cash Flow
-1.2B
↓ 61.55%
FY22Y/Y Change
Operating Cash Flow
2.3B
↓ 12.94%
Investing Cash Flow
-787.1M
↓ 38.58%
Financing Cash Flow
-1.7B
↑ 57.89%
Q3 FY22Q/Q Change
Operating Cash Flow
646.4M
↓ 12.48%
Investing Cash Flow
-99.1M
↓ 49.01%
Financing Cash Flow
-494.0M
↓ 31.0%
Q4 FY22Q/Q Change
Operating Cash Flow
642.7M
↓ 8.76%
Investing Cash Flow
-787.1M
↑ 628.95%
Financing Cash Flow
-128.5M
↓ 76.14%
Q1 FY23Q/Q Change
Operating Cash Flow
155.8M
↓ 76.19%
Investing Cash Flow
-178.1M
↓ 77.78%
Financing Cash Flow
2.2M
↓ 101.68%
Q2 FY23Q/Q Change
Operating Cash Flow
1.1B
↑ 605.11%
Investing Cash Flow
-323.6M
↑ 81.67%
Financing Cash Flow
-766.6M
↓ 34983.76%
Q3 FY23Q/Q Change
Operating Cash Flow
759.8M
↓ 24.56%
Investing Cash Flow
-447.7M
↑ 50.94%
Financing Cash Flow
-412.3M
↓ 41.31%

Technicals Summary

Sell

Neutral

Buy

Fresenius Medical Care Ag is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Fresenius Medical Care Ag
Fresenius Medical Care Ag
13.53%
23.8%
-7.73%
-45.32%
-46.38%
Hca Holdings, Inc.
Hca Holdings, Inc.
-2.41%
41.74%
13.28%
59.27%
156.45%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
-4.68%
74.59%
41.83%
75.13%
300.25%
Universal Health Services Inc.
Universal Health Services Inc.
-7.28%
34.94%
17.19%
13.12%
25.22%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-0.64%
65.1%
53.39%
18.14%
148.49%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Fresenius Medical Care Ag
Fresenius Medical Care Ag
22.58
22.58
0.39
2.02
0.05
0.03
0.03
46.42
Hca Holdings, Inc.
Hca Holdings, Inc.
16.37
16.37
1.44
20.64
0.12
0.11
0.01
-6.68
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
17.14
17.14
2.2
6.03
0.26
0.06
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
15.75
15.75
1.87
13.45
0.12
0.05
0.01
91.53
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
17.86
17.86
1.16
9.01
0.39
0.06
NA
11.89
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$12.2B
-46.38%
22.58
2.57%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$82.1B
156.45%
16.37
8.07%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$9.7B
300.25%
17.14
2.97%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$10.8B
25.22%
15.75
5.03%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$11.6B
148.49%
17.86
5.7%

Institutional Holdings

  • Pzena Investment Management, LLC

    2.77%
  • Fiduciary Management, Inc. of Milwaukee

    0.97%
  • Dodge & Cox

    0.72%
  • Goldman Sachs Group Inc

    0.21%
  • Amvescap Plc.

    0.17%
  • Morgan Stanley - Brokerage Accounts

    0.16%

Corporate Announcements

  • Fresenius Medical Care Ag Dividends September,2024

    In the quarter ending September,2024. Fresenius Medical Care Ag has declared dividend of $0.63

    Read More

Company Information

Fresenius Medical Care AG & Co. KGaA is an American German healthcare company which provides kidney dialysis services.

Organization
Fresenius Medical Care Ag
Employees
119845
CEO
Ms. Helen Giza
Industry
Health Services

FAQs